Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, al ...
China NMPA grants breakthrough therapy designation to Kelun-Biotech’s sacituzumab tirumotecan in combo with immunotherapy pembrolizumab for first-line treatment of PD-L1-positive NSCLC ...
Gyre Pharmaceuticals completed a Pre-NDA meeting with China’s CDE, which agreed that the existing Phase 3 clinical data support a conditional ...
Overview: Bybit offers spot, futures, and options trading with high liquidity.Beginners should start with spot trading before ...
Lackawanna County judge says township officials acted fairly in 2024 when they denied company’s plan to build a solar farm on ...
This normalization of mobile finance has important implications. Users are not experimenting with FinTech platforms on the ...
A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered ...
News-Medical.Net on MSN
Unveiling genetic links between schizophrenia and osteoporosis
A comprehensive genetic investigation led by Dr. Feng Liu at Tianjin Medical University General Hospital has uncovered ...
NovaBridge Also Included in the Highly Regarded Nasdaq Biotech Index, Emphasizing its Position as an Industry Leader Opening ...
Suzanne Nossel's book Dare to Speak argues that free speech should be defended for all, and that the erosion of support for ...
TipRanks on MSN
HUHUTECH International calls January 2026 EGM to approve major share consolidation and charter amendments
HUHUTECH International Group Inc. ( ($HUHU) ) just unveiled an update. HUHUTECH International Group Inc., a Cayman Islands–incorporated company ...
GBP/USD has moved into a clearly constructive zone, trading most of the day between 1.3520 and 1.3560 after tagging a fresh three-month high at 1.3562 in early Asian dealing and then spiking again ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results